Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
2022-05-17 $0.460 $0.471 $0.445 $0.460 44 957
2022-05-16 $0.448 $0.480 $0.430 $0.448 363 358
2022-05-13 $0.410 $0.456 $0.410 $0.444 231 410
2022-05-12 $0.422 $0.422 $0.402 $0.410 368 903
2022-05-11 $0.425 $0.433 $0.425 $0.425 289 349
2022-05-10 $0.420 $0.435 $0.420 $0.420 287 609
2022-05-09 $0.450 $0.450 $0.405 $0.407 1 091 095
2022-05-06 $0.503 $0.516 $0.454 $0.466 552 058
2022-05-05 $0.520 $0.574 $0.504 $0.518 320 567
2022-05-04 $0.520 $0.539 $0.509 $0.536 180 366
2022-05-03 $0.510 $0.575 $0.500 $0.549 518 382
2022-05-02 $0.510 $0.534 $0.500 $0.522 271 355
2022-04-29 $0.530 $0.570 $0.500 $0.515 516 413
2022-04-28 $0.570 $0.590 $0.464 $0.570 1 645 631
2022-04-27 $0.740 $0.780 $0.550 $0.610 8 588 558
2022-04-26 $0.643 $0.643 $0.630 $0.630 123 142
2022-04-25 $0.640 $0.659 $0.640 $0.640 184 398
2022-04-22 $0.650 $0.670 $0.640 $0.640 80 000
2022-04-21 $0.660 $0.670 $0.650 $0.650 74 000
2022-04-20 $0.650 $0.690 $0.650 $0.660 93 900
2022-04-19 $0.680 $0.690 $0.640 $0.650 316 800
2022-04-18 $0.680 $0.700 $0.670 $0.670 70 600
2022-04-14 $0.700 $0.711 $0.680 $0.680 46 259
2022-04-13 $0.680 $0.710 $0.680 $0.701 113 983
2022-04-12 $0.700 $0.710 $0.680 $0.680 198 681
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT